New England Biolabs Gets $1.2M SBIR Grant for Epigenetics Research | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – New England Biolabs announced this week that it has received a $1.2 million fast track Small Business Innovation Research grant for research into and development of enzymatic reagents for epigenetics.

The funding will further work NEB has been conducting into the MspJI family of restriction enzymes. The Ipswich, Mass.-based firm recently identified the enzyme family and demonstrated its use in mapping epigenetic modifications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.

Feb
23
Sponsored by
NuGEN

This webinar will discuss a project that sought to understand the parent-of-origin epigenetic mechanisms that regulate seed development in plants, with a particular emphasis on differentiating the maternal or paternal origin of epigenetics marks.